<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2413-4341</journal-id>
<journal-title><![CDATA[Revista Paraguaya de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. parag. reumatol.]]></abbrev-journal-title>
<issn>2413-4341</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Reumatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2413-43412021000100013</article-id>
<article-id pub-id-type="doi">10.18004/rpr/2021.07.01.13</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Espectro Clínico y Biomarcadores Genéticos de susceptibilidad en el síndrome de Vogt-Koyanagi- Harada en pacientes Paraguayos]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical spectrum and genetic biomarkers of susceptibility in Vogt-Koyanagi- Harada syndrome in Paraguayan patients]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[McLeod]]></surname>
<given-names><![CDATA[Nelly Colman]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Riquelme-Granada]]></surname>
<given-names><![CDATA[Susan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Losanto]]></surname>
<given-names><![CDATA[Jhonatan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[Marcos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[Maria Eugenia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espinosa Garriga]]></surname>
<given-names><![CDATA[Gerard]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta Colmán]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez de Filártiga]]></surname>
<given-names><![CDATA[María Teresa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Asunción Facultad de Ciencias Médicas Hospital de Clínicas, Departamento de Reumatología]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Asunción Instituto de investigación en Ciencias de la Salud Departamento de Producción]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Clinic Servicio de Enfermedades Autoinmunes y Sistémicas ]]></institution>
<addr-line><![CDATA[Barcelona ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Laboratorio Curie  ]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>7</volume>
<numero>1</numero>
<fpage>13</fpage>
<lpage>22</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2413-43412021000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2413-43412021000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2413-43412021000100013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN: Introducción: La enfermedad de Vogt-Koyanagi-Harada (VKH) es de etiología autoinmune y severa, se manifiesta con panuveítis bilateral y puede afectar sistema neuroauditivo y piel. La influencia de los factores genéticos en la expresión de VKH, ha quedado en evidencia en múltiples estudios. Posee mal pronóstico visual si se realiza el diagnóstico y el tratamiento en forma tardía, contar con biomarcadores genéticos susceptibilidad podrían ser de gran ayuda. El objetivo de este estudio es describir el espectro clínico y determinar biomarcadores genéticos de susceptibilidad en la enfermedad de VKH. Metodología: Estudio de casos y controles, de susceptibilidad genética para VKH. Se procedió al registro clínico de los pacientes y genotipado HLA DRB1 a casos y controles. Resultados: se incluyeron 21 pacientes con VKH para el registro clínico, de éstos se enrolaron 16 para el genotipado HLA-DRB1, los controles sanos incluidos fueron 32. Sexo fe menino 81%, edad promedio 35 años, las formas clínicas fueron VKH Probable 10(47,6%) y VKH incompleto 10(47,6%), VKH Completo 1 caso (4,7%) Genotipado: los alelos del grupo HLA DRB1*02 estaban presentes 5 de los 16 pacientes (31%) (p 0,004) y ausente en los controles, no se encontró relación con alelos específicos. El alelo más frecuente fue HLA DRB1*01:02 presente en 4 (25) % de casos y ausente en los controles. Conclusión: La mayoría de los pacientes fueron adultos jóvenes, predominancia del sexo femenino, las formas clínicas VKH Probables e Incompleta fueron más comunes. Se ha encontrado en esta cohorte paraguaya asociación genética de la enfermedad de VKH con alelos del grupo DRB1*02, no se halló relación estadísticamente significativa con ningún alelo específico, probablemente esto se debió a que la muestra fue pequeña. El alelo más frecuente HLA DRB1*01:02 podría ser un candidato a biomarcador genético en esta población.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT: Background: Vogt-Koyanagi-Harada (VKH) syndrome is a severe disease with autoimmune etiology. It manifests with bilateral panuveitis and can affect the nervous and auditory system, as well as the skin. The influence of genetic factors on the expression of VKH has been evidenced in multiple studies. It has a poor visual prognosis if diagnosis and treatment are delayed. Having biomarkers of genetic susceptibility could be of great help. The aim of this study is to describe the clinical spectrum and determine genetic biomarkers of susceptibility in VKH disease. Methodology: Case-control study of genetic susceptibility for VKH. Clinical data was registered and HLA DRB1 genotyping of cases and controls was performed. Results: 21 patients with VKH were included for the clinical registry, 16 of these were enrolled for HLA-DRB1 genotyping. Thirty two healthy controls were included. Most patients were female (81%,) average age 35 years, the clinical forms were: Probable VKH 10 (47.6%) and Incomplete VKH 10 (47.6%), Complete VKH 1 case (4.7%). Genotyping: alleles of the HLA DRB1*02 group were present in 5 of the 16 patients (31%) (p0.004) and absent in the controls, no relationship with specific alleles was found. The most frequent allele was HLA DRB1*01:02 present in 4 (25%)of cases and absent in controls. Conclusion: Most of the patients were young female adults. Probable and Incomplete forms were more common. Genetic association of VKH disease with alleles of the DRB1*02 group was found in this Paraguayan cohort. No statistically significant relationship was found with any specific allele, probably because the sample was small. The most frequent allele HLA DRB1*01:02 could be a candidate genetic biomarker in this population.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Vogt-Koyanagi- Harada]]></kwd>
<kwd lng="es"><![CDATA[HLA]]></kwd>
<kwd lng="es"><![CDATA[uveítis]]></kwd>
<kwd lng="en"><![CDATA[Vogt-Koyanagi-Harada]]></kwd>
<kwd lng="en"><![CDATA[HLA]]></kwd>
<kwd lng="en"><![CDATA[uveitis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Read]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Tabbara]]></surname>
<given-names><![CDATA[KF]]></given-names>
</name>
<name>
<surname><![CDATA[Ohno]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arellanes-garcia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revised Diagnostic Criteria for]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2001</year>
<numero>131</numero>
<issue>131</issue>
<page-range>647-52</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koyanagi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Attia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Khochtali]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kahloun]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zaouali]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Khairallah]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vogt - Koyanagi]]></article-title>
<source><![CDATA[Harada disease]]></source>
<year>2014</year>
<page-range>9899</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rathinam]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Tugal-tutkun]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Muccioli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zierhut]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[ET]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vogt-Koyanagi-Harada Disease Vogt- Koyanagi]]></article-title>
<source><![CDATA[Harada Disease]]></source>
<year>2014</year>
<page-range>3948</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alâez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Flores-a]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Elena]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Munguîa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrîguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Garcîa]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Major histocompatibility complex and strong human leukocyte antigen - DRB1 and gender association with Vogt - Koyanagi]]></article-title>
<source><![CDATA[Harada syndrome in Mexican Mestizos]]></source>
<year>2011</year>
<volume>72</volume>
<page-range>1198-203</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cantor]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Rapuano]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cioffi]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Read]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Acharya]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Levinson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation I.]]></article-title>
<source><![CDATA[Intraocular Inflammation and Uveitis]]></source>
<year>2018</year>
<page-range>71-100</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lv]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of hla-dr4/hla- drb104 with vogt-koyanagi-harada disease: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2014</year>
<volume>4</volume>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menezo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[SRJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of HLA-DRB1 * 04 in Malay patients with Vogt-Koyanagi]]></article-title>
<source><![CDATA[Harada syndrome]]></source>
<year>2019</year>
<page-range>82-3</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sukavatcharin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vogt-Koyanagi-Harada disease in hispanic patients]]></article-title>
<source><![CDATA[Int Ophthalmol]]></source>
<year>2007</year>
<volume>27</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>143-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singhal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Internacional Journal of Scientific Reserch the Clinical Spectrum of Vogt Koyanagi Harada Syndrome in a tertiary]]></article-title>
<source><![CDATA[Pathology Abstract]]></source>
<year>2019</year>
<numero>3</numero>
<issue>3</issue>
<page-range>40-2</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iqniebi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gaafar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sheereen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Suliman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamed]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Al- Hussein]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HLA-DRB1 among patients with Vogt-Koyanagi- Harada diseasein Saudi Arabia]]></article-title>
<source><![CDATA[Mol Vis]]></source>
<year>2009</year>
<volume>15</volume>
<page-range>1876-80</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Society]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aus]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Workshop]]></surname>
<given-names><![CDATA[VKHI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ScienceDirect &#8220;Revised diagnostic criteria &#8221; for Vogt-Koyanagi]]></article-title>
<source><![CDATA[Harada disease fail to improve disease management]]></source>
<year>2019</year>
<volume>31</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lavezzo]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Sakata]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Morita]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ernesto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Abdallah]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vogt-Koyanagi-Harada disease : review of a rare autoimmune disease targeting antigens of melanocytes]]></article-title>
<source><![CDATA[Orphanet J Rare Dis]]></source>
<year>2016</year>
<page-range>1-21</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abu El-Asrar]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Dosari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hemachandran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gikandi]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Muammar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of &#8216;sunset glow fundus&#8217; in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2017</year>
<volume>95</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>85-90</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chi]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and evaluation of diagnostic criteria for vogt-koyanagi-harada disease]]></article-title>
<source><![CDATA[JAMA Ophthalmol]]></source>
<year>2018</year>
<volume>136</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1025-31</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On the interpretation of &#967;2 from contingency tables, and the calculation of P]]></article-title>
<source><![CDATA[Journal of the Royal Statistical Society]]></source>
<year>1992</year>
<volume>85</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>87-94</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[Statistical Methods for Research Workers]]></source>
<year>1954</year>
<publisher-name><![CDATA[Oliver and Boyd]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agresti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Survey of Exact Inference for Contingency Tables]]></article-title>
<source><![CDATA[Statistical Science]]></source>
<year>1992</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>131-53</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chee]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Jap]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bacsal]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spectrum of Vogt-Koyanagi-Harada disease in Singapore]]></article-title>
<source><![CDATA[Int Ophthalmol]]></source>
<year>2007</year>
<volume>27</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>137-42</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Meng]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Kijlstra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Characteristics of Vogt-Koyanagi-Harada Syndrome in Chinese Patients]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2007</year>
<volume>114</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Concha-del Río]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Arellanes-García]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Corticotherapy vs. Corticotherapy Plus Immunosuppressive Therapy in Acute Vogt-Koyanagi-Harada Disease]]></article-title>
<source><![CDATA[Arch Soc Esp Oftalmol]]></source>
<year>2018</year>
<volume>93</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>225-30</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shindo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Inoko]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ohno]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HLA-DRB1 typing of Vogt- Koyanagi-Harada&#8217;s disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410]]></article-title>
<source><![CDATA[Br J Ophthalmol]]></source>
<year>1994</year>
<volume>78</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>223-6</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weisz]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Roer]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Yuge]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Moorthy]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between Vogt-Koyanagi-Harada Syndrome and HLA-DR1 and -DR4 in Hispanic Patients Living in Southern California]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>1995</year>
<volume>102</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1012-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arellanes-García]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bautista]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega-Larrocea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Burguet]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gorodezky]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HLA-DR is strongly associated with Vogt-Koyanagi- Harada disease in Mexican Mestizo patients]]></article-title>
<source><![CDATA[Ocul Immunol Inflamm]]></source>
<year>1998</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-100</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levinson]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[See]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Rajalingam]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada&#8217;s disease in Southern California]]></article-title>
<source><![CDATA[Hum Immunol]]></source>
<year>2004</year>
<volume>65</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1477-82</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
